title: Voluntary exercise protects against acute doxorubicin cardiotoxicity in the isolated perfused rat heart.
abstract: The clinical use of doxorubicin (DOX) is limited by a dose-dependent cardiotoxicity. The purpose of this study was to determine whether voluntary exercise training would confer protection against DOX cardiotoxicity in the isolated perfused rat heart. Female Sprague-Dawley rats were randomly assigned to standard holding cages or cages with running wheels for 8 wk. Twenty-four hours after the sedentary (SED) or voluntary exercise (VEX) running period, rats were anesthetized with pentobarbital sodium, and hearts were isolated and perfused with oxygenated Krebs-Henseleit (KH) buffer at a constant flow of 15 ml/min. After a 20-min stabilization period, hearts were paced at 300 beats per minute and perfused with KH buffer containing 10 microM DOX for 60 min. A set of control hearts from SED and VEX rats were perfused under identical conditions without DOX for the same period. DOX perfusion led to significant decreases in left ventricular developed pressure, +dP/dt, and -dP/dt, and significant increases in LV lipid peroxidation in sedentary rats compared with non-DOX controls (P < 0.05). Prior voluntary exercise training attenuated these DOX-induced effects and was associated with a significant increase (78%, P < 0.05) in heat shock protein (HSP72), but not mitochondrial isoform of SOD (MnSOD) or CuZnSOD protein expression in the hearts of wheel-run animals. These data indicate that chronic physical activity may provide resistance against the cardiac dysfunction and oxidative damage associated with DOX exposure and provide novel evidence of HSP72 induction in the heart after voluntary exercise.
authors.affiliation: School of Sport and Exercise Science, University of Northern Colorado, Greeley, CO 80639, USA.
authors.forename: Adam J
authors.initials: AJ
authors.lastname: Chicco
authors.forename: Carole M
authors.initials: CM
authors.lastname: Schneider
authors.forename: Reid
authors.initials: R
authors.lastname: Hayward
mesh_terms: D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000506:poisoning*; D004317:Doxorubicin / Q000506:poisoning*; D005260:Female; D050884:HSP72 Heat-Shock Proteins; D006321:Heart / Q000187:drug effects* / Q000502:physiology*; D006352:Heart Ventricles; D006360:Heat-Shock Proteins / Q000378:metabolism; D066298:In Vitro Techniques; D015227:Lipid Peroxidation / Q000187:drug effects; D009043:Motor Activity / Q000502:physiology*; D009206:Myocardium / Q000378:metabolism; D010477:Perfusion; D051381:Rats; D017207:Rats, Sprague-Dawley; D013482:Superoxide Dismutase / Q000378:metabolism; D013997:Time Factors; D016277:Ventricular Function, Left / Q000187:drug effects
chemical_list: D000903:Antibiotics, Antineoplastic; D050884:HSP72 Heat-Shock Proteins; D006360:Heat-Shock Proteins; D004317:Doxorubicin; D013482:Superoxide Dismutase